Daily

HTG Molecular Diagnostics, Inc. (NasdaqCM:HTGM), HBM Healthcare Investments AG (SWX:HBMN): Will These Stocks Go The Extra Mile?

The Current Ratio of HTG Molecular Diagnostics, Inc. (NasdaqCM:HTGM) is 5.42.  The Current Ratio is used by investors to determine whether a company can pay short term and long term debts.  The current ratio looks at all the liquid and non-liquid assets compared to the company’s total current liabilities.  A high current ratio indicates that the company has little trouble managing their working capital.  A low current ratio (when the current liabilities are higher than the current assets) indicates that the company may have trouble paying their short term obligations.

For the average investor, figuring out how to best approach the stock market can be challenging. Many investors have probably seen at least one of their prized stocks take off in the last year, and they may be wondering which one is next. With the stock market still trading at super high levels, investors may be worried that a major shift will occur in the near future. Looking back over the first part of this year, investors may not have too much to fidget within the portfolio. If the stock market decides to reverse course and take a turn for the worse, investors may start questioning their strategy and become somewhat worried. Drastic shifts in the markets happen from time to time. Investors who are prepared for volatile market environments may be much better suited to weather the storm than those who are not. Crafting a plan that accounts for the regular ups and downs of the market may be a wise choice for the individual investor. This may mean shifting the mindset to be on the lookout for opportunities when they become available. Investors who have done the research and planning might be more secure in their stock choices should turbulent times arise.

Volatility & Price

Stock volatility is a percentage that indicates whether a stock is a desirable purchase.  Investors look at the Volatility 12m to determine if a company has a low volatility percentage or not over the course of a year.  The Volatility 12m of HTG Molecular Diagnostics, Inc. (NasdaqCM:HTGM) is 70.120800.  This is calculated by taking weekly log normal returns and standard deviation of the share price over one year annualized.  The lower the number, a company is thought to have low volatility.  The Volatility 3m is a similar percentage determined by the daily log normal returns and standard deviation of the share price over 3 months.  The Volatility 3m of HTG Molecular Diagnostics, Inc. (NasdaqCM:HTGM) is 68.178700.  The Volatility 6m is the same, except measured over the course of six months.  The Volatility 6m is 69.973300.

We can now take a quick look at some historical stock price index data. HTG Molecular Diagnostics, Inc. (NasdaqCM:HTGM) presently has a 10 month price index of 0.74085. The price index is calculated by dividing the current share price by the share price ten months ago. A ratio over one indicates an increase in share price over the period. A ratio lower than one shows that the price has decreased over that time period. Looking at some alternate time periods, the 12 month price index is 0.72253, the 24 month is 0.44426, and the 36 month is 0.99245. Narrowing in a bit closer, the 5 month price index is 0.79217, the 3 month is 1.16372, and the 1 month is currently 1.10042.

The Leverage Ratio of HTG Molecular Diagnostics, Inc. (NasdaqCM:HTGM) is 0.297692.  Leverage ratio is the total debt of a company divided by total assets of the current and past year divided by two.  Companies take on debt to finance their day to day operations.  The leverage ratio can measure how much of a company’s capital comes from debt.  With this ratio, investors can better estimate how well a company will be able to pay their long and short term financial obligations.

C-Score
HTG Molecular Diagnostics, Inc. (NasdaqCM:HTGM) currently has a Montier C-score of 2.00000. This indicator was developed by James Montier in an attempt to identify firms that were cooking the books in order to appear better on paper. The score ranges from zero to six where a 0 would indicate no evidence of book cooking, and a 6 would indicate a high likelihood. A C-score of -1 would indicate that there is not enough information available to calculate the score. Montier used six inputs in the calculation. These inputs included a growing difference between net income and cash flow from operations, increasing receivable days, growing day’s sales of inventory, increasing other current assets, decrease in depreciation relative to gross property plant and equipment, and high total asset growth.

F Score, ERP5 and Magic Formula

The Piotroski F-Score is a scoring system between 1-9 that determines a firm’s financial strength.  The score helps determine if a company’s stock is valuable or not.  The Piotroski F-Score of HTG Molecular Diagnostics, Inc. (NasdaqCM:HTGM) is 6.  A score of nine indicates a high value stock, while a score of one indicates a low value stock.  The score is calculated by the return on assets (ROA), Cash flow return on assets (CFROA), change in return of assets, and quality of earnings.  It is also calculated by a change in gearing or leverage, liquidity, and change in shares in issue.  The score is also determined by change in gross margin and change in asset turnover.

The ERP5 Rank is an investment tool that analysts use to discover undervalued companies.  The ERP5 looks at the Price to Book ratio, Earnings Yield, ROIC and 5 year average ROIC.  The ERP5 of HTG Molecular Diagnostics, Inc. (NasdaqCM:HTGM) is 16868.  The lower the ERP5 rank, the more undervalued a company is thought to be. The MF Rank (aka the Magic Formula) is a formula that pinpoints a valuable company trading at a good price.  The formula is calculated by looking at companies that have a high earnings yield as well as a high return on invested capital.  The MF Rank of HTG Molecular Diagnostics, Inc. (NasdaqCM:HTGM) is 17253.  A company with a low rank is considered a good company to invest in.  The Magic Formula was introduced in a book written by Joel Greenblatt, entitled, “The Little Book that Beats the Market”.

Shareholder Yield

The Q.i. Value of HTG Molecular Diagnostics, Inc. (NasdaqCM:HTGM) is 85.00000.  The Q.i. Value is a helpful tool in determining if a company is undervalued or not.  The Q.i. Value is calculated using the following ratios: EBITDA Yield, Earnings Yield, FCF Yield, and Liquidity.  The lower the Q.i. value, the more undervalued the company is thought to be.  The Value Composite One (VC1) is a method that investors use to determine a company’s value.  The VC1 of HTG Molecular Diagnostics, Inc. (NasdaqCM:HTGM) is 91.  A company with a value of 0 is thought to be an undervalued company, while a company with a value of 100 is considered an overvalued company.  The VC1 is calculated using the price to book value, price to sales, EBITDA to EV, price to cash flow, and price to earnings.  Similarly, the Value Composite Two (VC2) is calculated with the same ratios, but adds the Shareholder Yield.  The Value Composite Two of HTG Molecular Diagnostics, Inc. (NasdaqCM:HTGM) is 95.

Traders may be going deeper into the playbook in order to scoop up profits in the current stock market environment. The first half of the year has produced plenty of big winners. Investors will be closely monitoring the most recent earnings releases to hopefully spot the next big mover. Traders may be looking to more closely define some major trends in order to identify which way the momentum is going to carry the stock market into the close of the calendar year. Keeping track of all the financial news and global happenings can be a tall order, even for the most seasoned investors. Staying the course while following a sound investing plan can help the individual investor become prepared for whatever lies ahead. The optimists still believe there is much more room for growth in the markets while the pessimists are calling for a major reversal in the near future. Traders and investors will be closely tracking the major economic news to help come to a solid conclusion about which way the markets are headed. Staying up on the fundamentals as well as the popular technical indicators may help the investor sort through the maze and prepare for the next stage.

HBM Healthcare Investments AG (SWX:HBMN) presently has a current ratio of 0.09. The current ratio, also known as the working capital ratio, is a liquidity ratio that displays the proportion of current assets of a business relative to the current liabilities. The ratio is simply calculated by dividing current liabilities by current assets. The ratio may be used to provide an idea of the ability of a certain company to pay back its liabilities with assets. Typically, the higher the current ratio the better, as the company may be more capable of paying back its obligations.

Investors may be taking a look at certain business aspects when attempting to research a stock. Investors often look to see if the stock’s specific industry is on the rise. There may be a greater chance of success when investing in an industry that is rapidly growing. Investors may then want to see how the company stacks up within the industry. Many investors will look for stocks that are proven industry leaders. Industry leaders have the ability to influence pricing and not necessarily be susceptible to what other companies are doing around them. Investors may also be taking note of how a company invests in research and development. Companies that are focused on the future may have a competitive advantage over those who are too focused on the near-term.

Volatility & Price

Stock volatility is a percentage that indicates whether a stock is a desirable purchase.  Investors look at the Volatility 12m to determine if a company has a low volatility percentage or not over the course of a year.  The Volatility 12m of HBM Healthcare Investments AG (SWX:HBMN) is 19.296900.  This is calculated by taking weekly log normal returns and standard deviation of the share price over one year annualized.  The lower the number, a company is thought to have low volatility.  The Volatility 3m is a similar percentage determined by the daily log normal returns and standard deviation of the share price over 3 months.  The Volatility 3m of HBM Healthcare Investments AG (SWX:HBMN) is 14.238200.  The Volatility 6m is the same, except measured over the course of six months.  The Volatility 6m is 20.279700.

We can now take a quick look at some historical stock price index data. HBM Healthcare Investments AG (SWX:HBMN) presently has a 10 month price index of 1.05495. The price index is calculated by dividing the current share price by the share price ten months ago. A ratio over one indicates an increase in share price over the period. A ratio lower than one shows that the price has decreased over that time period. Looking at some alternate time periods, the 12 month price index is 1.15354, the 24 month is 1.58053, and the 36 month is 1.86714. Narrowing in a bit closer, the 5 month price index is 0.98107, the 3 month is 1.00485, and the 1 month is currently 0.98926.

F Score, ERP5 and Magic Formula

The Piotroski F-Score is a scoring system between 1-9 that determines a firm’s financial strength.  The score helps determine if a company’s stock is valuable or not.  The Piotroski F-Score of HBM Healthcare Investments AG (SWX:HBMN) is 3.  A score of nine indicates a high value stock, while a score of one indicates a low value stock.  The score is calculated by the return on assets (ROA), Cash flow return on assets (CFROA), change in return of assets, and quality of earnings.  It is also calculated by a change in gearing or leverage, liquidity, and change in shares in issue.  The score is also determined by change in gross margin and change in asset turnover.

The ERP5 Rank is an investment tool that analysts use to discover undervalued companies.  The ERP5 looks at the Price to Book ratio, Earnings Yield, ROIC and 5 year average ROIC.  The ERP5 of HBM Healthcare Investments AG (SWX:HBMN) is 3025.  The lower the ERP5 rank, the more undervalued a company is thought to be. The MF Rank (aka the Magic Formula) is a formula that pinpoints a valuable company trading at a good price.  The formula is calculated by looking at companies that have a high earnings yield as well as a high return on invested capital.  The MF Rank of HBM Healthcare Investments AG (SWX:HBMN) is 5618.  A company with a low rank is considered a good company to invest in.  The Magic Formula was introduced in a book written by Joel Greenblatt, entitled, “The Little Book that Beats the Market”.

The Leverage Ratio of HBM Healthcare Investments AG (SWX:HBMN) is 0.114979.  Leverage ratio is the total debt of a company divided by total assets of the current and past year divided by two.  Companies take on debt to finance their day to day operations.  The leverage ratio can measure how much of a company’s capital comes from debt.  With this ratio, investors can better estimate how well a company will be able to pay their long and short term financial obligations.

The Q.i. Value of HBM Healthcare Investments AG (SWX:HBMN) is 36.00000.  The Q.i. Value is a helpful tool in determining if a company is undervalued or not.  The Q.i. Value is calculated using the following ratios: EBITDA Yield, Earnings Yield, FCF Yield, and Liquidity.  The lower the Q.i. value, the more undervalued the company is thought to be.  The Value Composite One (VC1) is a method that investors use to determine a company’s value.  The VC1 of HBM Healthcare Investments AG (SWX:HBMN) is 45.  A company with a value of 0 is thought to be an undervalued company, while a company with a value of 100 is considered an overvalued company.  The VC1 is calculated using the price to book value, price to sales, EBITDA to EV, price to cash flow, and price to earnings.  Similarly, the Value Composite Two (VC2) is calculated with the same ratios, but adds the Shareholder Yield.  The Value Composite Two of HBM Healthcare Investments AG (SWX:HBMN) is 35.

C-Score
HBM Healthcare Investments AG (SWX:HBMN) currently has a Montier C-score of -1.00000. This indicator was developed by James Montier in an attempt to identify firms that were cooking the books in order to appear better on paper. The score ranges from zero to six where a 0 would indicate no evidence of book cooking, and a 6 would indicate a high likelihood. A C-score of -1 would indicate that there is not enough information available to calculate the score. Montier used six inputs in the calculation. These inputs included a growing difference between net income and cash flow from operations, increasing receivable days, growing day’s sales of inventory, increasing other current assets, decrease in depreciation relative to gross property plant and equipment, and high total asset growth.

Figuring out when to sell a stock can be just as important as deciding what stocks to buy at the outset. Some investors may refuse to sell based on various factors. Investors may have become stubborn, too emotionally attached, or set too high of an expectation for a stock. Holding on to a stock for way too long in order to squeeze every last drop of profit out of a price move may leave the investor desperately searching for answers in the future. Investors may have different checklists for when it is time to sell a stock. Of course this depends largely on the individual and how much is at risk. Often times, investors will make a move to sell when the fundamentals drastically change, the dividend is cut, or a previous set target price has been hit. Getting out of a position at the right time is obviously not easy, but it may become a bit easier with time and research.